Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.295B-$1.365B vs $1.334B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Indivior Pharmaceuticals (NASDAQ:INDV) affirms FY2026 sales outlook from $1.295 billion-$1.365 billion to $1.295 billion-$1.365 billion vs $1.334 billion estimate.
Indivior Pharmaceuticals (NASDAQ:INDV) affirms FY2026 sales outlook from $1.295 billion-$1.365 billion to $1.295 billion-$1.365 billion vs $1.334 billion estimate.